TCWA
CC icon

Turtle Creek Wealth Advisors’s Chemours CC Stock Holding History

Turtle Creek Wealth Advisors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-470
Closed -$14.8K – 295
2023
Q4 		$14.8K Buy
+470
New +$12.8K ﹤0.01% 476

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Turtle Creek Wealth Advisors's CC Position: Q1 2024 in Review

Turtle Creek Wealth Advisors sold out of Chemours (CC) in Q1 2024, closing a stake of 470 shares — an estimated $14.8K sold.

Turtle Creek Wealth Advisors first reported a position in CC in Q4 2023 and held it in 1 quarter. The position peaked at $14.8K in Q4 2023. 443 funds tracked by Wall St. Rank hold CC as of Q1 2024.

  • Turtle Creek Wealth Advisors reported no remaining Chemours position as of Q1 2024 after selling out during the quarter.
  • Turtle Creek Wealth Advisors sold 470 Chemours shares in Q1 2024, an estimated $14.8K.
  • Turtle Creek Wealth Advisors first reported a position in Chemours in Q4 2023 and held it in 1 quarter.
  • Turtle Creek Wealth Advisors's Chemours position peaked at $14.8K in Q4 2023.
  • 443 funds tracked by Wall St. Rank held Chemours as of Q1 2024.

Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.